Alan M. Hanash

9.1k total citations · 1 hit paper
51 papers, 2.2k citations indexed

About

Alan M. Hanash is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Alan M. Hanash has authored 51 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 25 papers in Hematology and 12 papers in Oncology. Recurrent topics in Alan M. Hanash's work include Immune Cell Function and Interaction (25 papers), Hematopoietic Stem Cell Transplantation (24 papers) and IL-33, ST2, and ILC Pathways (12 papers). Alan M. Hanash is often cited by papers focused on Immune Cell Function and Interaction (25 papers), Hematopoietic Stem Cell Transplantation (24 papers) and IL-33, ST2, and ILC Pathways (12 papers). Alan M. Hanash collaborates with scholars based in United States, Netherlands and Germany. Alan M. Hanash's co-authors include Marcel R.M. van den Brink, Jarrod A. Dudakov, Robert B. Levy, Robert R. Jenq, Odette M. Smith, Lauren Young, Natalie V. Singer, Mallory L. West, Amanda M. Holland and Jennifer J. Tsai and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Alan M. Hanash

49 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-22: Immunobiology and Pathology

2015 685 citations Jarrod A. Dudakov, Alan M. Hanash et al. Annual Review of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan M. Hanash United States	17	1.4k	532	441	401	299	51	2.2k
Cristina Tecchio Italy	26	1.3k 0.9×	332 0.6×	784 1.8×	681 1.7×	158 0.5×	71	2.7k
Taku Kouro Japan	24	2.0k 1.4×	485 0.9×	575 1.3×	493 1.2×	281 0.9×	51	2.9k
Femke van Wijk Netherlands	33	1.5k 1.1×	302 0.6×	589 1.3×	420 1.0×	199 0.7×	113	3.2k
Alla Skapenko Germany	25	1.4k 1.0×	284 0.5×	768 1.7×	532 1.3×	113 0.4×	69	2.8k
Antonio López‐Vázquez Spain	33	1.8k 1.3×	430 0.8×	258 0.6×	251 0.6×	259 0.9×	70	2.8k
Takashi Yahata Japan	25	1.5k 1.1×	667 1.3×	809 1.8×	599 1.5×	227 0.8×	65	3.0k
Hiroki Mitoma Japan	24	1.3k 1.0×	271 0.5×	767 1.7×	320 0.8×	225 0.8×	68	2.9k
Genevieve Whitty Australia	21	1.4k 1.0×	648 1.2×	757 1.7×	651 1.6×	155 0.5×	35	2.9k
Ιoannis Kotsianidis Greece	23	809 0.6×	475 0.9×	795 1.8×	303 0.8×	101 0.3×	113	2.2k
Kenichi Koike Japan	28	788 0.6×	789 1.5×	879 2.0×	400 1.0×	163 0.5×	158	2.5k

Countries citing papers authored by Alan M. Hanash

Since Specialization

Citations

This map shows the geographic impact of Alan M. Hanash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan M. Hanash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan M. Hanash more than expected).

Fields of papers citing papers by Alan M. Hanash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan M. Hanash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan M. Hanash. The network helps show where Alan M. Hanash may publish in the future.

Co-authorship network of co-authors of Alan M. Hanash

This figure shows the co-authorship network connecting the top 25 collaborators of Alan M. Hanash. A scholar is included among the top collaborators of Alan M. Hanash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan M. Hanash. Alan M. Hanash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Winston, Suze A. Jansen, Govindarajan Thangavelu, et al.. (2024). Corticosteroids impair epithelial regeneration in immune-mediated intestinal damage. Journal of Clinical Investigation. 134(7). 7 indexed citations

Calafiore, Marco, Ya–Yuan Fu, Paola Vinci, et al.. (2023). A tissue-intrinsic IL-33/EGF circuit promotes epithelial regeneration after intestinal injury. Nature Communications. 14(1). 5411–5411. 22 indexed citations

Jansen, Suze A., Edward E. S. Nieuwenhuis, Alan M. Hanash, & Caroline A. Lindemans. (2022). Challenges and opportunities targeting mechanisms of epithelial injury and recovery in acute intestinal graft-versus-host disease. Mucosal Immunology. 15(4). 605–619. 11 indexed citations

Bourcier, Jessie, Simon J. Hogg, Caroline Erickson, et al.. (2022). Attenuation of Graft-Versus-Host-Disease Via Genetic or Pharmacologic Inhibition of the RNA Splicing Factor RBM39. Blood. 140(Supplement 1). 1163–1164.

Saxton, Robert A., Lukas T. Henneberg, Marco Calafiore, et al.. (2021). The tissue protective functions of interleukin-22 can be decoupled from pro-inflammatory actions through structure-based design. Immunity. 54(4). 660–672.e9. 49 indexed citations

Ponce, Doris M., Amin M. Alousi, Ryotaro Nakamura, et al.. (2020). A Phase 2 Study of F-652, a Novel Tissue-Targeted Recombinant Human Interleukin-22 (IL-22) Dimer, for Treatment of Newly Diagnosed Acute Gvhd of the Lower GI Tract. Biology of Blood and Marrow Transplantation. 26(3). S51–S52. 9 indexed citations

Fu, Ya–Yuan, Catherine Sobieski, Marco Calafiore, et al.. (2019). T Cell Recruitment to the Intestinal Stem Cell Compartment Drives Immune-Mediated Intestinal Damage after Allogeneic Transplantation. Immunity. 51(1). 90–103.e3. 67 indexed citations

Dudakov, Jarrod A., Anna Mertelsmann, Margaret O'Connor, et al.. (2017). Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease. Blood. 130(7). 933–942. 55 indexed citations

Dudakov, Jarrod A., Alan M. Hanash, & Marcel R.M. van den Brink. (2015). Interleukin-22: Immunobiology and Pathology. Annual Review of Immunology. 33(1). 747–785. 685 indexed citations breakdown →

10.

Purtill, Duncan, Cladd E. Stevens, Marissa Lubin, et al.. (2015). Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation. Biology of Blood and Marrow Transplantation. 21(11). 1981–1984. 5 indexed citations

11.

Harnicar, Stephen, Doris M. Ponce, Patrick Hilden, et al.. (2015). Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation. Biology of Blood and Marrow Transplantation. 21(5). 920–925. 24 indexed citations

12.

Lindemans, Caroline A., Anna Mertelsmann, Jarrod A. Dudakov, et al.. (2014). IL-22 Administration Protects Intestinal Stem Cells from Gvhd. Biology of Blood and Marrow Transplantation. 20(2). S53–S54. 1 indexed citations

13.

Tsai, Jennifer J., Jarrod A. Dudakov, Koichi Takahashi, et al.. (2013). Nrf2 regulates haematopoietic stem cell function. Nature Cell Biology. 15(3). 309–316. 167 indexed citations

14.

Mertelsmann, Anna, Jarrod A. Dudakov, Enrico Velardi, et al.. (2013). IL-22 Administration Decreases Intestinal Gvhd Pathology, Increases Intestinal Stem Cell Recovery, and Enhances Immune Reconstitution Following Allogeneic Hematopoietic Transplantation. Blood. 122(21). 290–290. 1 indexed citations

15.

Dudakov, Jarrod A., Alan M. Hanash, Robert R. Jenq, et al.. (2012). Interleukin-22 Drives Endogenous Thymic Regeneration in Mice. Science. 336(6077). 91–95. 286 indexed citations

16.

Holland, Amanda M., Johannes L. Zakrzewski, Jennifer J. Tsai, et al.. (2012). Extrathymic development of murine T cells after bone marrow transplantation. Journal of Clinical Investigation. 122(12). 4716–4726. 15 indexed citations

17.

Hanash, Alan M., Jarrod A. Dudakov, Guoqiang Hua, et al.. (2012). IL-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft vs. host disease (126.31). The Journal of Immunology. 188(1_Supplement). 126.31–126.31. 1 indexed citations

18.

Dudakov, Jarrod A., Alan M. Hanash, Robert R. Jenq, et al.. (2012). Interleukin-22 drives endogenous thymic regeneration in mice (44.6). The Journal of Immunology. 188(1_Supplement). 44.6–44.6. 10 indexed citations

19.

Brink, Marcel R.M. van den, David L. Porter, Sergio Giralt, et al.. (2009). Relapse after Allogeneic Hematopoietic Cell Therapy. Biology of Blood and Marrow Transplantation. 16(1). S138–S145. 70 indexed citations

20.

Jiang, Zhe, Gregor B. Adams, Alan M. Hanash, David T. Scadden, & Robert B. Levy. (2002). The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation. Biology of Blood and Marrow Transplantation. 8(11). 588–596. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact